Omnicare Holds Annual Stockholders' Meeting

COVINGTON, Ky.--(BUSINESS WIRE)-- Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, today held its Annual Meeting of Stockholders.

At the meeting, Omnicare stockholders elected the seven directors who stood for election to the Company's Board of Directors to serve until the 2011 Annual Meeting or until their respective successors are duly elected and qualified.

Also during the meeting, Omnicare stockholders ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the Company for 2010.

Omnicare, Inc. (NYSE:OCR), a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare’s pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in 32 countries worldwide.

For more information on Omnicare, visit www.omnicare.com.



CONTACT:

Omnicare, Inc.
Cheryl D. Hodges, 859-392-3331

KEYWORDS:   United States  North America  Kentucky  Ohio

INDUSTRY KEYWORDS:   Health  Hospitals  Pharmaceutical  General Health  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.